Figures & data
Figure 2. Evolution over time of meningococcal vaccination strategies in European countries.
![Figure 2. Evolution over time of meningococcal vaccination strategies in European countries.](/cms/asset/bd2945c7-2649-40e3-a33d-97edf38cdac3/ypgh_a_1972663_f0002_oc.jpg)
Figure 3. Evolution of serogroup-specific invasive meningococcal disease incidence and meningococcal vaccination strategies for 5 European countries.
![Figure 3. Evolution of serogroup-specific invasive meningococcal disease incidence and meningococcal vaccination strategies for 5 European countries.](/cms/asset/4130b77d-592b-4fb5-ab24-4d0f6b590930/ypgh_a_1972663_f0003_oc.jpg)
Figure 4. Distribution of reported serogroup-specific invasive meningococcal disease cases by age in European countries, 2014–2018
![Figure 4. Distribution of reported serogroup-specific invasive meningococcal disease cases by age in European countries, 2014–2018](/cms/asset/bd05ba72-d114-4f74-ab32-5a6405cc976c/ypgh_a_1972663_f0004_oc.jpg)
Figure 5. Introduction of routine meningococcal vaccination and current vaccination schedule in non-European countries
![Figure 5. Introduction of routine meningococcal vaccination and current vaccination schedule in non-European countries](/cms/asset/efaac94d-2843-4202-98a6-405db489fd40/ypgh_a_1972663_f0005_oc.jpg)